Julián Olalla

1.5k total citations
69 papers, 534 citations indexed

About

Julián Olalla is a scholar working on Infectious Diseases, Emergency Medicine and Epidemiology. According to data from OpenAlex, Julián Olalla has authored 69 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 28 papers in Emergency Medicine and 24 papers in Epidemiology. Recurrent topics in Julián Olalla's work include HIV-related health complications and treatments (26 papers), HIV/AIDS drug development and treatment (24 papers) and HIV/AIDS Research and Interventions (18 papers). Julián Olalla is often cited by papers focused on HIV-related health complications and treatments (26 papers), HIV/AIDS drug development and treatment (24 papers) and HIV/AIDS Research and Interventions (18 papers). Julián Olalla collaborates with scholars based in Spain, United States and France. Julián Olalla's co-authors include Alfonso del Arco, Javier de la Torre, José Luís Prada, Javier García‐Alegría, Elia Palenque, Rafael Rubio, Federico Pulido, José Hernández‐Rodríguez, Daniel Salas and José Ramón Blanco and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Julián Olalla

62 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julián Olalla Spain 12 232 154 104 95 86 69 534
Lolita Sasset Italy 15 269 1.2× 179 1.2× 98 0.9× 86 0.9× 22 0.3× 48 571
Güliz Erdem United States 16 249 1.1× 215 1.4× 75 0.7× 195 2.1× 129 1.5× 82 843
Magnus Glindvad Ahlström Denmark 10 210 0.9× 177 1.1× 97 0.9× 26 0.3× 55 0.6× 27 427
Maxime Hentzien France 14 215 0.9× 122 0.8× 70 0.7× 43 0.5× 26 0.3× 60 527
F Mignone Italy 11 176 0.8× 98 0.6× 49 0.5× 105 1.1× 36 0.4× 27 354
N. Mémain France 9 371 1.6× 392 2.5× 92 0.9× 222 2.3× 65 0.8× 16 685
José Mayo Spain 16 283 1.2× 208 1.4× 143 1.4× 116 1.2× 24 0.3× 33 639
Bernardino Roca Spain 14 232 1.0× 153 1.0× 55 0.5× 95 1.0× 41 0.5× 54 507
Amélie Menard France 11 261 1.1× 85 0.6× 128 1.2× 85 0.9× 20 0.2× 26 497
Sebastian Noé Germany 11 137 0.6× 161 1.0× 49 0.5× 96 1.0× 20 0.2× 38 500

Countries citing papers authored by Julián Olalla

Since Specialization
Citations

This map shows the geographic impact of Julián Olalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julián Olalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julián Olalla more than expected).

Fields of papers citing papers by Julián Olalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julián Olalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julián Olalla. The network helps show where Julián Olalla may publish in the future.

Co-authorship network of co-authors of Julián Olalla

This figure shows the co-authorship network connecting the top 25 collaborators of Julián Olalla. A scholar is included among the top collaborators of Julián Olalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julián Olalla. Julián Olalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Izquierdo, Rebeca, Alejandro Vallejo, Inés Suárez‐García, et al.. (2025). Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 274–282.
3.
Olalla, Julián, et al.. (2024). Potential role of lung ultrasonography in outpatient follow-up of patients with COVID-19. A systematic review. Revista Clínica Española (English Edition). 225(2). 101–110. 1 indexed citations
4.
Moreno, Santiago, Bernardino Alcázar Navarrete, Carlos Dueñas, et al.. (2022). Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir. SHILAP Revista de lepidopterología. 15 indexed citations
5.
Moreno, Santiago, Noemí Cabello, Pablo Ryan, et al.. (2022). Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study. Journal of Clinical Medicine. 11(17). 4994–4994. 2 indexed citations
6.
Suárez‐García, Inés, Marta Ruiz‐Algueró, Belén Alejos, et al.. (2022). Brief Report: Patients' Experiences and Opinions After Desimplification of Their Single-Tablet Regimens for the Treatment of HIV Infection: A Survey in a Multicentre Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(1). 62–68.
7.
Berenguer, Juan, Inmaculada Jarrín, José M. Bellón, et al.. (2022). Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy. Clinical Infectious Diseases. 76(6). 977–985. 5 indexed citations
8.
Blanco, José Luís, José Ramón Blanco, Julián Olalla, et al.. (2021). A prospective case-cohort study of covid-19 in persons with hiv: Covih-19 study. 29(1). 248–248.
9.
Blanco, José Ramón, Francisco Arnaíz de las Revillas, Enrique Bernal, et al.. (2021). Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clinical Microbiology and Infection. 27(6). 892–896. 76 indexed citations
10.
11.
Rivas‐Ruiz, Francisco, et al.. (2020). Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes. Diabetes Research and Clinical Practice. 162. 108094–108094. 3 indexed citations
12.
Olalla, Julián, José María García de Lomas Guerrero, Alfonso del Arco, et al.. (2018). Experience of Using an App in HIV Patients Older Than 60 Years: Pilot Program. JMIR mhealth and uhealth. 7(3). e9904–e9904. 8 indexed citations
13.
Olalla, Julián, et al.. (2017). Reconstitution Inflammatory Syndrome Like Reactive Hemophagocytic Syndrome Associated with Disseminated Histoplasmosis in a HIV Patient. Mycopathologia. 182(7-8). 767–770. 14 indexed citations
14.
Olalla, Julián, Elena Crespo, Javier de la Torre, et al.. (2015). Factors related to NT-proBNP levels in HIV patients aged over 40 years. AIDS Research and Therapy. 12(1). 17–17. 8 indexed citations
15.
Blanco, José Ramón, Ana María Caro-Murillo, Julián Olalla, et al.. (2013). Safety, Efficacy, and Persistence of Emtricitabine/Tenofovir Versus Other Nucleoside Analogues in Naive Subjects Aged 50 Years or Older in Spain: The TRIP Study. HIV Clinical Trials. 14(5). 204–215. 2 indexed citations
16.
Arco, Alfonso del, et al.. (2011). Programa de asesoramiento en tratamiento antibiótico en un hospital de segundo nivel: resultados de un año de actuación. Revista española de quimioterapia. Suplemento. 24(2). 96–98. 4 indexed citations
17.
Salas, Daniel, Julián Olalla, Alfonso del Arco, et al.. (2010). Factores asociados a índice tobillo-brazo alterado en una cohorte de pacientes con infección por el virus de la inmunodeficiencia humana de tipo 1. Medicina Clínica. 135(12). 533–536. 3 indexed citations
18.
Palacios, Rosario, et al.. (2010). Short Communication: Contribution of the Immunovirological State and Traditional Cardiovascular Risk Factors to Low HDL-Cholesterol in HIV Patients. AIDS Research and Human Retroviruses. 26(11). 1167–1170. 2 indexed citations
19.
Olalla, Julián, et al.. (2002). Paradoxical responses in a cohort of HIV-1-infected patients with mycobacterial disease.. PubMed. 6(1). 71–5. 47 indexed citations
20.
Olalla, Julián, et al.. (2002). Mycobacterium fortuitum complex endocarditis—case report and literature review. Clinical Microbiology and Infection. 8(2). 125–129. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lolita Sasset Breakdown of academic impact, for papers by Güliz Erdem Breakdown of academic impact, for papers by Magnus Glindvad Ahlström Breakdown of academic impact, for papers by Maxime Hentzien Breakdown of academic impact, for papers by F Mignone Breakdown of academic impact, for papers by N. Mémain Breakdown of academic impact, for papers by José Mayo Breakdown of academic impact, for papers by Bernardino Roca Breakdown of academic impact, for papers by Amélie Menard Breakdown of academic impact, for papers by Sebastian Noé
Rankless by CCL
2026